|
|
Reports |
|
|
Clinical Genomics
|
The Impact of Genomic Technology on Clinical Trials and Medical Practice
by Gwen Acton, PhD
This report assesses the challenges and future prospects for incorporating genomics technologies into standard clinical practice. The report examines some of the ways in which genomics could directly contribute to clinical practice, evaluates the scientific, technological, legal, and regulatory issues that will have a significant impact on the future adoption of genomics in clinical settings, and discusses the emerging business opportunities that will arise as the widespread application of genomics to clinical drug development, diagnostics, and medical practice comes to fruition
More Information And To Order report published April 2006
(Link to first edition published April 2004)
|
Toxicology
|
Toxicogenomics and Predictive Toxicology: Market and Business Outlook
by Gwen Acton, PhD
This report addresses the significant need and potential for predictive toxicology in drug development. The report evaluates a number of novel approaches to toxicology research that have become available over the past five years that are raising optimism for dramatic improvements in the field. A detailed and insightful business outlook on the strategic, regulatory, and marketplace issues driving growth of toxicogenomic and predictive toxicology applications completes the analysis.
More Information and To Order
|
|
|
|
|
|
|
|
|